Foundation Medical Partners Welcomes Lawrence Calcano as Venture Partner

Calcano Brings Information Technology Deal Experience to Investment Team

ROWAYTON, CT, March 12, 2013-- Foundation Medical Partners, a national healthcare venture capital investment firm, today announced that Lawrence Calcano has joined the team as a Venture Partner. Mr. Calcano joins Foundation's healthcare investment team in assessing and managing investments in the connected health and healthcare IT sectors.
Calcano has spent a significant portion of his career working with growth technology oriented companies from multiple vantage points, including as CEO, director, investor, and outside financial advisor.

Calcano was at Goldman Sachs for almost seventeen years, where he became a Partner in the Investment Banking Division and served as Co-Head or COO of the firm’s Technology Banking Group ("the Tech Group") from 1997 to 2006, and Head of the firm’s East Coast Technology Group beginning in 1993. Calcano has deep domain knowledge and deal experience working with startup and growth companies in technology, the internet, and e-commerce.

He has served as an adviser to the CEOs of many of the most exciting growth companies over the years and has worked on over $40 billion transactions of all types, including public and private financings as well as mergers and acquisitions. In addition, Calcano was named to the Forbes Midas List of the most influential people in venture capital in 2001 (the inaugural year), 2002, 2004, 2005 and 2006. Calcano has served on the Boards of Directors for several companies over the years including 800Flowers, Freemarkets, Capital Acquisition Corp, ECI, Pivot Point Software, and Bite Tech.

Mr. Calcano is currently CEO of i1 Biometrics, a connected health company that is developing sensors, wireless connectivity, and data analytics for sports and military applications (a Foundation portfolio company). i1 Biometrics is a spinout of Bite Tech, Inc., a maker of athletic protective and performance oriented devices, where Calcano served as Chairman and CEO for two and a half years.

"Lawrence brings experience in IT and deal structuring to Foundation," said Andrew Firlik, Managing Partner of Foundation Medical Partners. "He has worked with some of the fastest growing companies in the past two decades and he knows how to help them succeed.”

Mr. Calcano joins the investment team at Foundation Medical Partners that includes partners Andrew Firlik, Lee Wrubel, Kevin Sharer, and Ted Laufik. The firm actively manages over $200 million in venture capital targeted toward start-up and early-stage companies. Foundation has remained exclusively focused on the healthcare technology market since the firm was founded in 2001, with a current market capitalization of its healthcare investments totaling approximately $2.0 billion.

About Foundation Medical Partners

Foundation Medical Partners is a national venture capital investment firm formed in 2001 with the vision of bringing together cutting edge healthcare expertise with deep company building experience. Foundation specializes in early stage venture capital for healthcare technology companies. Foundation Medical Partners was an early, active venture investor in many companies that subsequently went public or were acquired in strategic transactions, such as AtriCure (NASDAQ: ATRC), CardioNet (NASDAQ: BEAT), Combinatorx (NASDAQ: ZLCS), Immunicon (NASDAQ: IMMC, later acquired by Johnson & Johnson), Northstar Neuroscience (NASDAQ: NSTR, later acquired by St. Jude Medical), and Visiogen (acquired by Abbott), as well as a portfolio of other market-leading privately held firms.

News Index

Downloadable Venture Capital Database